Gene therapy holds tremendous promise for treating a wide range of diseases and we're thrilled that Excision Chief Financial Officer, Christine Silverstein is a speaker at a
#BioFuture2023 panel, "Rewriting the Code: Navigating the Frontier of Gene & Cell Therapy.”